D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
Provided herein are compounds, compositions, and methods for the treatment of viral infections, for example, Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in com...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Gosselin, Gilles Pierra, Claire Dukhan, David Moussa, Adel M Dousson, Cyril B Mayes, Benjamin Alexander |
| description | Provided herein are compounds, compositions, and methods for the treatment of viral infections, for example, Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are D-amino acid phosphoramidate halogeno pyrimidine nucleoside analog compounds which display remarkable efficacy and bioavailability for the treatment of, for example, HCV infection in a human. In certain embodiments, the compounds are of Formula I: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: PD, X, R1, R2, RA, and RB are as described herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10238680B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10238680B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10238680B23</originalsourceid><addsrcrecordid>eNqNyk0KwjAQhuFuXIh6h_EAhdqCdO0f7tWtZUgmdiDNhEwqeHuz8AAuPl74eJbV81TjxEEADVuIo2hZKpfFTBCThNl4ksyWFMTBiF5eVHz8JC6KA4GRKcocrIKTBJ7flMCyEiqtq4VDr7T5dVVtL-f78VpTlIE0oqFAeXjcdk3b9fu-ObTdP-YLmjI9eg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease</title><source>esp@cenet</source><creator>Gosselin, Gilles ; Pierra, Claire ; Dukhan, David ; Moussa, Adel M ; Dousson, Cyril B ; Mayes, Benjamin Alexander</creator><creatorcontrib>Gosselin, Gilles ; Pierra, Claire ; Dukhan, David ; Moussa, Adel M ; Dousson, Cyril B ; Mayes, Benjamin Alexander</creatorcontrib><description>Provided herein are compounds, compositions, and methods for the treatment of viral infections, for example, Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are D-amino acid phosphoramidate halogeno pyrimidine nucleoside analog compounds which display remarkable efficacy and bioavailability for the treatment of, for example, HCV infection in a human. In certain embodiments, the compounds are of Formula I: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: PD, X, R1, R2, RA, and RB are as described herein.</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SUGARS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190326&DB=EPODOC&CC=US&NR=10238680B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190326&DB=EPODOC&CC=US&NR=10238680B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gosselin, Gilles</creatorcontrib><creatorcontrib>Pierra, Claire</creatorcontrib><creatorcontrib>Dukhan, David</creatorcontrib><creatorcontrib>Moussa, Adel M</creatorcontrib><creatorcontrib>Dousson, Cyril B</creatorcontrib><creatorcontrib>Mayes, Benjamin Alexander</creatorcontrib><title>D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease</title><description>Provided herein are compounds, compositions, and methods for the treatment of viral infections, for example, Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are D-amino acid phosphoramidate halogeno pyrimidine nucleoside analog compounds which display remarkable efficacy and bioavailability for the treatment of, for example, HCV infection in a human. In certain embodiments, the compounds are of Formula I: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: PD, X, R1, R2, RA, and RB are as described herein.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyk0KwjAQhuFuXIh6h_EAhdqCdO0f7tWtZUgmdiDNhEwqeHuz8AAuPl74eJbV81TjxEEADVuIo2hZKpfFTBCThNl4ksyWFMTBiF5eVHz8JC6KA4GRKcocrIKTBJ7flMCyEiqtq4VDr7T5dVVtL-f78VpTlIE0oqFAeXjcdk3b9fu-ObTdP-YLmjI9eg</recordid><startdate>20190326</startdate><enddate>20190326</enddate><creator>Gosselin, Gilles</creator><creator>Pierra, Claire</creator><creator>Dukhan, David</creator><creator>Moussa, Adel M</creator><creator>Dousson, Cyril B</creator><creator>Mayes, Benjamin Alexander</creator><scope>EVB</scope></search><sort><creationdate>20190326</creationdate><title>D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease</title><author>Gosselin, Gilles ; Pierra, Claire ; Dukhan, David ; Moussa, Adel M ; Dousson, Cyril B ; Mayes, Benjamin Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10238680B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>Gosselin, Gilles</creatorcontrib><creatorcontrib>Pierra, Claire</creatorcontrib><creatorcontrib>Dukhan, David</creatorcontrib><creatorcontrib>Moussa, Adel M</creatorcontrib><creatorcontrib>Dousson, Cyril B</creatorcontrib><creatorcontrib>Mayes, Benjamin Alexander</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gosselin, Gilles</au><au>Pierra, Claire</au><au>Dukhan, David</au><au>Moussa, Adel M</au><au>Dousson, Cyril B</au><au>Mayes, Benjamin Alexander</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease</title><date>2019-03-26</date><risdate>2019</risdate><abstract>Provided herein are compounds, compositions, and methods for the treatment of viral infections, for example, Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are D-amino acid phosphoramidate halogeno pyrimidine nucleoside analog compounds which display remarkable efficacy and bioavailability for the treatment of, for example, HCV infection in a human. In certain embodiments, the compounds are of Formula I: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: PD, X, R1, R2, RA, and RB are as described herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US10238680B2 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
| title | D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A37%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gosselin,%20Gilles&rft.date=2019-03-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10238680B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |